C18H15ClN2O2S
358.8 g/mol
APIDanger
Etoricoxib
CAS202409-33-4
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Etoricoxib is a selective COX-2 inhibitor used as an active pharmaceutical ingredient. It is approved in many countries for use in pharmaceutical manufacturing, though not in the United States, where additional data were requested by the FDA.
selective COX-2 inhibitoractive pharmaceutical ingredient
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 202409-33-4
Related Compounds
ReferenceSame Category
Safinamide mesylate
CAS202825-46-5
pharmaceutical raw material
ReferenceSame Category
Clofazimine
CAS2030-63-9
pharmaceutical raw material
ReferenceSame Category
Laninamivir octanoate
CAS203120-46-1
pharmaceutical raw material
ReferenceSame Category
Recoflavone
CAS203191-10-0
pharmaceutical raw material
Safety Reference
Danger
H302Harmful if swallowed
H310Fatal in contact with skin
H373May cause damage to organs through prolonged or repeated exposure
H411Toxic to aquatic life with long lasting effects
Identifiers
IUPAC Name
5-chloro-2-(6-methyl-3-pyridinyl)-3-(4-methylsulfonylphenyl)pyridine
InChIKey
MNJVRJDLRVPLFE-UHFFFAOYSA-N
SMILES
CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C
Synonyms (30)
- 5CH
- Etoricoxib (USAN/INN)
- Etoricoxib, United States Pharmacopeia (USP)
- Algix
- Arcoxia
- ETORICOXIB [MART.]
- Etoricoxib
- Etoricoxib (Standard)
- Etoricoxib - Bio-X trade mark
- Etoricoxib, VETRANAL(TM)
- Etoricoxib; MK-663; MK-0663
- Etoricoxibe
- Etoxib
- Etropain
- Kingcox
- MK-0663;L-791456
- Nucoxia
- Tauxib
- Torcoxia
- etoricoxibum